Adrian Wiestner is a Hematology physician affiliated with National Institutes of Health. OpenAlex indexes 766 publications with 18,519 citations (h-index 70); ClinicalTrials.gov lists 3 registered studies matched to this name. By OpenAlex citation count, this profile ranks in the top 10% of Hematology profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
10 Center Dr
Bethesda, MD 208920004
Telephone
301-594-6855Provider last certified this registry record 17 Nov 2023.
Clinical trials
- Epcoritamab in Chronic Lymphocytic Leukemia and Richter Syndrome
Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
- Vaccine Responses in Patients With B Cell Malignancies
Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
- Ibrutinib, Fludarabine, and Pembrolizumab in High-Risk or Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Genmab U.S., Inc.Program year20252 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Ibrutinib for Chronic Lymphocytic Leukemia with <i>TP53</i> Alterations
New England Journal of Medicine
2020 - Targeting B cell receptor signalling in cancer: preclinical and clinical advances
Nature reviews. Cancer
2018
Similar KOLs
Other experts from the same institution or the same specialty.
Edward Lakatta, MD
National Institutes of Health
Douglas Lowy, MD
National Institutes of Health
Jerome Fleg, MD
National Institutes of Health
Robert Star, MD
National Institutes of Health
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”